Effect of mitoxantrone on proliferation dynamics and cell-cycle progression

Bioscience Reports

Volumn 30, Issue 6, 2010, Pages 375-381

  Khan, Shahper N ^a   Lal, Sunil K ^b   Kumar, Purnima ^b   Khan, Asad U ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

Cell cycle arrest; Colony Forming Unit (CFU); Gene expression; Growth inhibition; Mitoxantrone (MTX)

Indexed keywords

BETA GALACTOSIDASE; MITOXANTRONE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ASSAY; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL DEATH; CELL DENSITY; CELL FUNCTION; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CHROMATIN CONDENSATION; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CULTURE MEDIUM; DNA CONTENT; DRUG EFFECT; ENZYME ACTIVITY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; FUNGAL CELL CULTURE; GENE EXPRESSION REGULATION; MITOSIS INHIBITION; NONHUMAN;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL PROLIFERATION; COLONY COUNT, MICROBIAL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, FUNGAL; LAC OPERON; MICROSCOPY, CONFOCAL; MITOXANTRONE; SACCHAROMYCES CEREVISIAE;

EID: 78650858777     PISSN: 01448463     EISSN: None     Source Type: Journal    
DOI: 10.1042/BSR20090119     Document Type: Article

References (26)

1. Albin, N., Massaad, L., Toussaint, C., Mathieu, M. C., Morizet, J., Parise, O., Gouyette, A. and Chabot, G. G. (1993) Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues. Cancer Res. 53, 3541-3546
2. Meister, A. (1995) Mitochondrial changes associated with glutathione deficiency. Biochim. Biophys. Acta 1271, 35-42
3. Hercbergs, A., Brok-Simoni, F., Holtzman, F., Bar-Am, J., Leith, J. T. and Brenner, H. J. (1992) Erythrocyte glutathione and tumour response to chemotherapy. Lancet 339, 1074-1076
4. Tew, K. D. (1994) Glutathione-associated enzymes in anticancer drug resistance. Cancer Res. 54, 4313-4320
5. O'Dwyer, P. J., Hamilton, T. C., Yao, K. S., Tew, K. D. and Ozols, R. F. (1995) Modulation of glutathione and related enzymes in reversal of resistance to anticancer drugs. Hematol. Oncol. Clin. North Am. 9, 383-389
6. Clifford, J., Chiba, H., Sobieszczuk, D., Metzger, D. and Chambon, P. (1996) RXRα-null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids. EMBO J. 15, 4142-4155
7. Haupt, Y., Barak, Y. and Oren, M. (1996) Cell type-specific inhibition of p53-mediated apoptosis by mdm2. EMBO J. 15, 1596-1606 (Pubitemid 26112381)
8. Darzynkiewicz, Z., Bruno, S., Del Bino, G., Gorczyca, W., Hotz, M. A., Lassotta, P. and Traganos, F. (1992) Features of apoptotic cells measured by flow cytometry. Cytometry 13, 795-808
9. Ellis, E., Yuan, J. and Horvitz, H. R. (1991) Mechanisms and functions of cells death. Annu. Rev. Cell 7, 663-698
10. Ameisen, J. C. (1996) The origin of programmed cell death. Science 272, 1278-1279
11. Xu, Q. and Reed, J. C. (1998) Bax inhibitor-1: a mammalian apoptosis suppressor identified by functional screening in yeast. Mol. Cell 1, 337-346
12. Tyagi, S., Korkaya, H., Zafrullah, M., Jameel, S. and Lal, S. K. (2002) The phosphorylated form of the ORF3 protein of hepatitis E virus interacts with its non-glycosylated form of the major capsid protein ORF2. J. Biol. Chem. 277, 22759-22767
13. Surjit, M., Jameel, S. and Lal, S. K. (2004) The ORF2 protein of hepatitis E virus binds the 5′ region of viral RNA. J. Virol. 78, 320-328
14. Murphree, S. A., Cunningham, K. M., Hwang, A. C. and Sartorelli, A. C. (1976) Effects of adriamycin on surface properties of sarcoma 180 ascites cells. Biochem. Pharmacol. 25, 1227-1231
15. Kessel, D. (1979) Enhanced glycosylation induced by adriamycin. Mol. Pharmacol. 16, 306-312
16. Tritton, T. R., Murphree, S. A. and Sartorelli, A. C. (1978) Adriamycin: a proposal on the specificity of drug action. Biochem. Biophys. Res. Commun. 84, 802-808
17. Murphree, S. A. and Tritton, T. R. (1979) Effects of DOX on liposomal and cellular membranes studied by magnetic resonance. Fed. Proc. 38, 258-263
18. Ferguson, L. R. and Turner, P. M. (1988) Mitotic crossing-over by anticancer drugs in Saccharomyces cerevisiae strain D5. Mutat. Res. 204, 239-249
19. Ormerod, M. G., Paul, F., Cheetham, M. and Sun, X. M. (1995) Discrimination of apoptotic thymocytes by forward light scatter. Cytometry 21, 300-304
20. Grana, X. and Reddy, P. (1995) Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CDKIs). Oncogene 11, 211-219
21. Schwartz, G. K. and Shah, M. A. (2005) Targeting the cell cycle: a new approach to cancer therapy. J. Clin. Oncol. 23, 9408-9421
22. 6 binuclear cluster proteins recognizes DNA. Mol. Cell Biol. 16, 3773-3780
23. Martin, B., Vaquero, A., Priebe, W. and Portugal, J. (1999) Bisanthracycline WP631 inhibits basal and Sp1-activated transcription initiation in vitro. Nucleic Acids Res. 27, 3402-3409
24. 2/M arrest and inhibition of c-myc and p53 transcription by WP631 in Jurkat T cells. Biochem. Pharmacol. 63, 1251-1258
25. Taylor, A., Webster, K. A., Gustafson, T. A. and Kedes, L. (1997) The anticancer agent distamycin A displaces essential transcription factors and selectively inhibits myogenic differentiation. Mol. Cell. Biochem. 169, 61-72
26. Resnick, M. A. and Cox, B. S. (2000) Yeast as an honorary mammal. Mutat. Res. 451, 1-11